|1.||Sánchez, Domènec J: 5 articles (06/2013 - 04/2010)|
|2.||Domingo, José L: 5 articles (06/2013 - 04/2010)|
|3.||Blanco, Jordi: 3 articles (06/2013 - 12/2011)|
|4.||Mulero, Miquel: 3 articles (06/2013 - 12/2011)|
|5.||Darnerud, Per Ola: 2 articles (06/2013 - 12/2007)|
|6.||Ilbäck, Nils-Gunnar: 2 articles (06/2013 - 12/2007)|
|7.||Lundgren, Magnus: 2 articles (06/2013 - 12/2007)|
|8.||Bellés, Montserrat: 2 articles (04/2010 - 04/2010)|
|9.||Sirvent, Juan J: 2 articles (04/2010 - 04/2010)|
|10.||Albina, Maria L: 2 articles (04/2010 - 04/2010)|
06/01/2013 - "When comparing infected mice exposed to the two BDE-99 doses, the higher BDE dose resulted in increased virus amounts in the liver, and decreased infection-induced expression of MCP-1. "
06/01/2013 - "In mice the common human coxsackievirus B3 (CVB3) infection has been shown to change the tissue distribution of BDE-99. "
12/05/2007 - "In the present study, CVB3 adapted to Balb/c mice was used to study the combined effects of infection and exposure to pure BDE-99 or the commercial mixture Bromkal on CYP1A1 and CYP2B expression in the lungs and pancreas on day 3 of the infection. "
06/01/2013 - "Moreover, the fact that CVB3 infection increased the BDE-99 levels in liver but not in serum may impair the risk assessment of polybrominated diphenyl ethers (PBDEs) in subclinical and clinically infected individuals, as serum levels is the common marker of exposure."
06/01/2013 - "We now investigate how CVB3 infection in mice affects liver uptake of (14)C at two doses of radiolabelled BDE-99, and whether increased tissue levels are related to changed virus replication and gene expression of the proinflammatory chemokine monocyte chemoattractant protein-1 (MCP-1). "
|2.||Colorectal Neoplasms (Colorectal Cancer)
|3.||Neoplasm Metastasis (Metastasis)
|4.||Body Weight (Weight, Body)
04/30/2010 - "Adult male rats (10 per group) received BDE-99 by gavage at a single dose of 0, 0.6, and 1.2mg/kg body weight. "
04/15/2010 - "Adult male rats (10/group) received BDE-99 by gavage at single doses of 0, 0.6 or 1.2mg/kg/body weight. "
07/15/2004 - "Higher tissue concentrations of BDE-99 were found in suckling neonates than in dams, probably due to a high dose per kilogram body weight from milk and an efficient absorption via the gastrointestinal tract in the pups."
04/30/2010 - "In kidney, CAT activity was significantly decreased, while GSSG/GSH ratio significantly increased following BDE-99 exposure at 1.2mg/kg body weight. "
08/15/2007 - "Tadpoles exposed to BDE-99 also showed lower developmental stage but no effects on body weight or body length, suggesting possible thyroid hormone disruption. "
|1.||Cytochrome P-450 CYP1A1 (CYP1A1)
|2.||pentabromodiphenyl ether (PBDE)
|3.||tetrabrominated diphenyl ether 47
|4.||Halogenated Diphenyl Ethers
|6.||pentabrominated diphenyl ether 100
|7.||Protein Isoforms (Isoforms)
|8.||Glutathione Disulfide (GSSG)
|9.||Brain-Derived Neurotrophic Factor (BDNF)
|10.||Chemokine CCL2 (Monocyte Chemoattractant Protein 1)